4.7 Article

Targeted Delivery of Liposomal Temozolomide Enhanced Anti-Glioblastoma Efficacy through Ultrasound-Mediated Blood-Brain Barrier Opening

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Inhibiting the Growth of 3D Brain Cancer Models with Bio-Coronated Liposomal Temozolomide

Giordano Perini et al.

Summary: Nanoparticles have been effective carriers for delivering anticancer drugs to the brain, with liposomal temozolomide being a preferred choice for treating brain tumors. However, the therapeutic benefit of liposomal TMZ is often suboptimal due to inefficient tumor penetration. Recent research has shown that the protein corona surrounding NPs after exposure to human plasma plays a crucial role in determining their anticancer efficacy by facilitating interactions with specific receptors of target cells. By coating liposomal TMZ with a protein corona made of human plasma proteins, researchers were able to increase drug penetration in a 3D brain cancer model and inhibit tumor growth. Fine-tuning the composition of the corona also showed varying effects on tumor growth, clarifying that certain protein corona fingerprints enable favored interactions with specific receptors of brain cancer cells. These findings suggest the potential of developing corona-coated liposomal drugs with enhanced tumor penetration and antitumor efficacy.

PHARMACEUTICS (2021)

Article Oncology

PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma

Shaofang Wu et al.

Summary: This study demonstrates the critical role of PARylation of MGMT by PARP in repairing TMZ-induced O-6-MetG, with PARP inhibitors reducing MGMT function and sensitizing GBM to TMZ. The findings provide a rationale for combining PARP inhibitors to enhance TMZ sensitivity in MGMT-unmethylated GBM.

NEURO-ONCOLOGY (2021)

Review Instruments & Instrumentation

Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme

Lynn Jena et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)

Review Biochemistry & Molecular Biology

Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets

Vishal Chavda et al.

CURRENT DRUG METABOLISM (2020)

Review Oncology

Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System

Hiromi Onizuka et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)

Review Oncology

MGMT Status as a Clinical Biomarker in Glioblastoma

Madison Butler et al.

TRENDS IN CANCER (2020)

Review Oncology

Glioblastoma vs temozolomide: can the red queen race be won?

Anjali Arora et al.

CANCER BIOLOGY & THERAPY (2019)

Review Oncology

Molecular targeted therapy of glioblastoma

Emilie Le Rhun et al.

CANCER TREATMENT REVIEWS (2019)

Review Clinical Neurology

Functional morphology of the blood-brain barrier in health and disease

Stefan Liebner et al.

ACTA NEUROPATHOLOGICA (2018)

Review Clinical Neurology

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Shabierjiang Jiapaer et al.

NEUROLOGIA MEDICO-CHIRURGICA (2018)

Article Multidisciplinary Sciences

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

Xiaoyue Chen et al.

NATURE COMMUNICATIONS (2018)

Review Chemistry, Medicinal

Gliomas: New Perspectives in Diagnosis, Treatment and Prognosis

Kemel A. Ghotme et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)

Review Oncology

Central nervous system gliomas

Michele Reni et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

Article Cell Biology

Clinical trial of blood-brain barrier disruption by pulsed ultrasound

Alexandre Carpentier et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Review Biochemistry & Molecular Biology

Temozolomide resistance in glioblastoma multiforme

Sang Y. Lee

GENES & DISEASES (2016)

Review Pharmacology & Pharmacy

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment

O. van Tellingen et al.

DRUG RESISTANCE UPDATES (2015)

Review Oncology

Surgical Management of Low-Grade Gliomas

Carter S. Gerard et al.

SEMINARS IN ONCOLOGY (2014)

Review Pharmacology & Pharmacy

Liposomal drug delivery systems: From concept to clinical applications

Theresa M. Allen et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Review Medicine, General & Internal

Glioblastoma and Other Malignant Gliomas A Clinical Review

Antonio Omuro et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Endocrinology & Metabolism

Blood-brain barrier structure and function and the challenges for CNS drug delivery

N. Joan Abbott

JOURNAL OF INHERITED METABOLIC DISEASE (2013)

Article Clinical Neurology

Radiation Options for High-Grade Gliomas

Benedict Beng Teck Taw et al.

NEUROSURGERY CLINICS OF NORTH AMERICA (2012)

Review Neurosciences

Structure and function of the blood-brain barrier

N. Joan Abbott et al.

NEUROBIOLOGY OF DISEASE (2010)

Article Chemistry, Multidisciplinary

Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic acid)

Rameshwar Patil et al.

PHARMACEUTICAL RESEARCH (2010)

Article Medicine, General & Internal

MGMT gene silencing and benefit from temozolomide in glioblastoma

ME Hegi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Therapeutic strategies and prospects of gliomas

S Taillibert et al.

PRESSE MEDICALE (2004)